Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aviceda Therapeutics, Inc.

Clinical trials sponsored by Aviceda Therapeutics, Inc., explained in plain language.

Not yet finished but already full! 1

New eye injection aims to halt blinding disease

Disease control Ongoing

This study is testing a new drug called AVD-104, given as an injection into the eye, for people with geographic atrophy (GA), a severe form of age-related macular degeneration that causes progressive vision loss. The main goal is to see if the drug is safe and if it can slow down…

Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC